
Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com
EUROPE BEFORE THE BELL: A MIXED BAG
European futures are a mixed bag on Friday morning, with the main Euro STOXX 50 futures STXEc1 down 0.1% while DAX futures are up FDXc1 0.2% and FTSE FFIc1 are down 0.5%
Nerves are frayed after a brutal week for software stocks, and the pain around tech might continue into Friday as eyes turn to Amazon.
Shares in the Mag-7 stock are down 10% in Europe after it became the latest hyperscaler to project massive capital expenditures 2026.
Elsewhere shares in Franco-Italian automaker Stellantis were down 5.7% in early trading on the Tradegate platform, after the company said was booking charges of around 22.2 billion euros ($26.5 billion) in the second half of last year as it scaled down its electric-vehicle development plans 8TI.F.
Societe Generale SOGN.PA lifted a key profitability target for 2026 after beating fourth-quarter profit forecasts. Shares are up around 1.6% on Tradegate.
Eyes will be on Novo Nordisk shares at the open after having dropped nearly 25% in three days. Novo stock is up over 2% in Frankfurt. The FDA has now threatened action on 'illegal copycat drugs', after Hims and Hers Health began offering a much cheaper $49 compounded version of Novo Nordisk's Wegovy weight-loss pill.
(Lucy Raitano)
FOR FRIDAY'S OTHER LIVE MARKETS POSTS
FED UNDER PRESSURE AS LAYOFFS MOUNT CLICK HERE